Puma Biotechnology
Puma Biotechnology is a biopharmaceutical company dedicated to the acquisition, development, and commercialization of novel therapeutics for the treatment of cancer.
Home About Us Product Pipeline News Investors Contacts Careers

News

Recent Press Releases Archives

Archives

2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011

2012 News Releases

December 7, 2012 - Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
Phase II Results Demonstrate Efficacy of PB272 in Combination with Temsirolimus in HER2+ Metastatic Breast Cancer
Read

Nov. 14, 2012 - Puma Biotechnology Reports Third Quarter 2012 Financial Results
Read

Nov. 7, 2012 - Puma Biotechnology to Present at Lazard Healthcare Conference
Read

October 24, 2012 - Puma Biotechnology Closes $138 Million Public Offering of Common Stock
Read

October 22, 2012 - Puma Biotechnology Announces Underwriters' Full Exercise of Overallotment Option, Increasing Total Offering Size to $138 Million
Read

October 18, 2012 - Puma Biotechnology Announces Upsizing and Pricing of $120 Million Public Offering of Common Stock
Read

September 12, 2012 - Puma Biotechnology to Present at UBS Global Life Sciences Conference
Read

August 29, 2012 - Puma Biotechnology to Present at Stifel Nicolaus 2012 Healthcare Conference
Read

August 14, 2012 - Puma Biotechnology Reports Second Quarter 2012 Financial Results
Read

August 7, 2012 - Puma Biotechnology to Present at Wedbush PacGrow Life Sciences Conference
Read

June 2, 2012 - Puma Biotechnology Presents Positive PB272 Clinical Data at ASCO 2012 Annual Meeting
Phase I Results Demonstrate Safety and Efficacy of PB272 in Combination with Paclitaxel and Trastuzumab in Women with Metastatic HER-2 Positive Breast Cancer
Read

May 30, 2012 - Puma Biotechnology to Present at Jefferies Healthcare Conference
Read

May 17, 2012 - Puma Biotechnology to Present Clinical Data on PB272 at ASCO 2012 Annual Meeting
Read

May 9, 2012 - Puma - Merrill Lynch Health Care Conference
Read

April 16, 2012 - Puma Biotechnology Cleared for Quotation on OTCBB and OTC LINK
Read

February 28, 2012 - Puma Biotechnology to Present at Cowen Health Care Conference
Read

February 9, 2012 - Puma Biotechnology to Present at Leerink Swann Global Healthcare Conference
Read

January 4, 2012 - Puma Biotechnology to Present at 30th Annual J.P. Morgan Healthcare Conference
Read




2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011


Corporate Fact Sheet

Puma Biotechnology, Inc.

10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024
424-248-6500 Main
424-248-6501 Fax